203 related articles for article (PubMed ID: 32943162)
1. Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
Sud M; Han L; Koh M; Abdel-Qadir H; Austin PC; Farkouh ME; Godoy LC; Lawler PR; Udell JA; Wijeysundera HC; Ko DT
J Am Coll Cardiol; 2020 Sep; 76(12):1440-1450. PubMed ID: 32943162
[TBL] [Abstract][Full Text] [Related]
2. Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization.
Farkouh ME; Godoy LC; Brooks MM; Mancini GBJ; Vlachos H; Bittner VA; Chaitman BR; Siami FS; Hartigan PM; Frye RL; Boden WE; Fuster V
J Am Coll Cardiol; 2020 Nov; 76(19):2197-2207. PubMed ID: 33153578
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation.
Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009
[TBL] [Abstract][Full Text] [Related]
4. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: a report from the CREDO-Kyoto registry cohort-2.
Izuhara M; Ono K; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Tada T; Tazaki J; Horie T; Kuwabara Y; Baba O; Nishino T; Kita T; Kimura T;
Atherosclerosis; 2015 Oct; 242(2):632-8. PubMed ID: 26022139
[TBL] [Abstract][Full Text] [Related]
6. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study.
Ren X; Wang X
Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of two low-density lipoprotein cholesterol goals for secondary prevention after acute myocardial infarction in real-world practice: ≥ 50% reduction from baseline versus <70 mg/dL.
Cho KH; Jeong MH; Park KW; Kim HS; Lee SR; Chae JK; Hong YJ; Kim JH; Ahn Y; Cho JG; Park JC;
Int J Cardiol; 2015; 187():478-85. PubMed ID: 25846658
[TBL] [Abstract][Full Text] [Related]
8. Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Zhang J; He L
BMC Cardiovasc Disord; 2021 Apr; 21(1):169. PubMed ID: 33845772
[TBL] [Abstract][Full Text] [Related]
9. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
[TBL] [Abstract][Full Text] [Related]
10. Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial.
Giugliano RP; Wiviott SD; Blazing MA; De Ferrari GM; Park JG; Murphy SA; White JA; Tershakovec AM; Cannon CP; Braunwald E
JAMA Cardiol; 2017 May; 2(5):547-555. PubMed ID: 28291866
[TBL] [Abstract][Full Text] [Related]
11. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
12. High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.
Kim J; Park KT; Jang MJ; Park TK; Lee JM; Yang JH; Song YB; Choi SH; Gwon HC; Lee SH; Hong KP; Hahn JY
J Am Heart Assoc; 2018 Nov; 7(21):e009517. PubMed ID: 30376751
[TBL] [Abstract][Full Text] [Related]
13. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention.
Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K
Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786
[TBL] [Abstract][Full Text] [Related]
14. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.
Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK
Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical impact of low-density lipoprotein cholesterol target attainment according to lesion complexity after percutaneous coronary intervention.
Kim BJ; Lee JH; Park JI; Nam JH; Lee CH; Son JW; Kim U; Shin DG; Park JS
Coron Artery Dis; 2022 Aug; 33(5):368-375. PubMed ID: 35131985
[TBL] [Abstract][Full Text] [Related]
16. Associations between lipid profiles and MACE in hemodialysis patients with percutaneous coronary intervention: from the FU-Registry.
Nagata I; Ike A; Nishikawa H; Zhang B; Sugihara M; Mori K; Iwata A; Kawamura A; Shirai K; Uehara Y; Ogawa M; Miura S; Saku K
J Cardiol; 2015 Feb; 65(2):105-11. PubMed ID: 24997801
[TBL] [Abstract][Full Text] [Related]
17. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry.
Matsuoka Y; Ike A; Ogawa M; Gondo K; Shirai K; Sugihara M; Nose D; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Yasunaga S; Miura SI; Saku K
J Cardiol; 2018 Mar; 71(3):259-267. PubMed ID: 29129396
[TBL] [Abstract][Full Text] [Related]
18. Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome.
Bittner VA; Szarek M; Aylward PE; Bhatt DL; Diaz R; Edelberg JM; Fras Z; Goodman SG; Halvorsen S; Hanotin C; Harrington RA; Jukema JW; Loizeau V; Moriarty PM; Moryusef A; Pordy R; Roe MT; Sinnaeve P; Tsimikas S; Vogel R; White HD; Zahger D; Zeiher AM; Steg PG; Schwartz GG;
J Am Coll Cardiol; 2020 Jan; 75(2):133-144. PubMed ID: 31948641
[TBL] [Abstract][Full Text] [Related]
19. Impact of Low Baseline Low-Density Lipoprotein Cholesterol on Long-Term Postdischarge Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.
Cho KH; Kim MC; Choo EH; Choi IJ; Lee SN; Park MW; Park CS; Kim HY; Kim CJ; Sim DS; Kim JH; Hong YJ; Jeong MH; Chang K; Ahn Y
J Am Heart Assoc; 2022 Sep; 11(17):e025958. PubMed ID: 36000434
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
Downs JR; Clearfield M; Weis S; Whitney E; Shapiro DR; Beere PA; Langendorfer A; Stein EA; Kruyer W; Gotto AM
JAMA; 1998 May; 279(20):1615-22. PubMed ID: 9613910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
